Norplant update.
D000569:Americas; D000830:Animals, Laboratory; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003695:Delivery of Health Care; D019049:Developed Countries; D003906:Developing Countries; D004194:Disease; D004467:Economics; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006077:Government Agencies; D006262:Health; D006285:Health Planning; D006298:Health Services Administration; D008099:Liver; D008113:Liver Neoplasms; D008389:Marketing of Health Services; D009369:Neoplasms; D009656:North America; D009934:Organization and Administration; D009938:Organizations; D012106:Research; D013672:Technology; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female
Americas; Animals, Laboratory; Cancer; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Implants--side effects; Contraceptive Methods--side effects; Delivery Of Health Care; Developed Countries; Developing Countries; Diseases; Economic Factors; Evaluation; Family Planning; Government Agencies; Health; Health Services Administration; Hepatic Effects; Liver Neoplasms; Management; Marketing--standards; Neoplasms; North America; Northern America; Organization And Administration; Organizations; Program Activities; Programs; Research And Development; Research Methodology; Technology; United States